HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States.
+ 1 more risk
Reasonable growth potential with imperfect balance sheet.
Share Price & News
How has HealthEquity's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HQY's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: HQY underperformed the US Healthcare industry which returned 12.5% over the past year.
Return vs Market: HQY underperformed the US Market which returned 18% over the past year.
Price Volatility Vs. Market
How volatile is HealthEquity's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StShould You Investigate HealthEquity, Inc. (NASDAQ:HQY) At US$71.38?
3 weeks ago | Simply Wall StAre HealthEquity's (NASDAQ:HQY) Statutory Earnings A Good Reflection Of Its Earnings Potential?
1 month ago | Simply Wall StDid You Miss HealthEquity's (NASDAQ:HQY) Impressive 264% Share Price Gain?
Is HealthEquity undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HQY ($87.73) is trading below our estimate of fair value ($105.58)
Significantly Below Fair Value: HQY is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: HQY is poor value based on its PE Ratio (107.4x) compared to the Healthcare industry average (30.1x).
PE vs Market: HQY is poor value based on its PE Ratio (107.4x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: HQY is poor value based on its PEG Ratio (4.3x)
Price to Book Ratio
PB vs Industry: HQY is overvalued based on its PB Ratio (6.1x) compared to the US Healthcare industry average (3x).
How is HealthEquity forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HQY's forecast earnings growth (25.2% per year) is above the savings rate (1.7%).
Earnings vs Market: HQY's earnings (25.2% per year) are forecast to grow faster than the US market (14.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HQY's revenue (19.3% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: HQY's revenue (19.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HQY's Return on Equity is forecast to be low in 3 years time (18.3%).
How has HealthEquity performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HQY has a large one-off loss of $35.4M impacting its October 31 2019 financial results.
Growing Profit Margin: HQY's current net profit margins (13%) are lower than last year (24.5%).
Past Earnings Growth Analysis
Earnings Trend: HQY's earnings have grown significantly by 40.5% per year over the past 5 years.
Accelerating Growth: HQY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HQY had negative earnings growth (-20.6%) over the past year, making it difficult to compare to the Healthcare industry average (13.9%).
Return on Equity
High ROE: HQY's Return on Equity (5.2%) is considered low.
Return on Assets
Return on Capital Employed
How is HealthEquity's financial position?
Financial Position Analysis
Short Term Liabilities: HQY's short term assets ($270.3M) exceed its short term liabilities ($141.9M).
Long Term Liabilities: HQY's short term assets ($270.3M) do not cover its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: HQY's debt to equity ratio (120.6%) is considered high.
Reducing Debt: Insufficient data to determine if HQY's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: HQY's debt is not well covered by operating cash flow (8.7%).
Interest Coverage: HQY's interest payments on its debt are well covered by EBIT (24.1x coverage).
Inventory Level: HQY has a low level of unsold assets or inventory.
Debt Coverage by Assets: HQY's debt is not covered by short term assets (assets are 0.2x debt).
What is HealthEquity's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate HQY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate HQY's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HQY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HQY's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HQY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jon Kessler (51yo)
Mr. Jon Kessler is serving as Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President at HealthEquity, Inc. since February 2014. Mr. Kessler fou ...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD4.81M) is about average for companies of similar size in the US market ($USD6.35M).
Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.
|Founder & Vice Chairman||6yrs||US$1.87m||1.1% $68.4m|
|Executive VP & CFO||13yrs||US$1.86m||0.042% $2.6m|
|Executive VP & COO||1.5yrs||US$2.46m||0.014% $863.1k|
|Executive VP||7yrs||US$2.99m||0.043% $2.7m|
|Vice President of Investor Relations||0yrs||no data||no data|
|Executive VP||3.4yrs||US$1.53m||0.0097% $603.8k|
|Senior VP of Compliance & Regulatory Affairs||0.4yrs||no data||no data|
|Senior Vice President of Corporate Development||2.8yrs||no data||no data|
|Executive Vice President of Sales||2.8yrs||US$2.09m||0.019% $1.2m|
Experienced Management: HQY's management team is considered experienced (3.4 years average tenure).
|Founder & Vice Chairman||6yrs||US$1.87m||1.1% $68.4m|
|Independent Director||3.4yrs||US$205.00k||0.037% $2.3m|
|Non-Executive Chairman||4.4yrs||US$305.00k||0.038% $2.3m|
|Independent Director||5.6yrs||US$245.00k||0.016% $1.0m|
|Independent Director||5.6yrs||US$205.00k||0.0065% $401.1k|
|Independent Director||15.8yrs||US$210.00k||0.21% $13.1m|
|Independent Director||13.3yrs||US$220.00k||0.021% $1.3m|
|Independent Director||2.5yrs||US$205.00k||0.011% $672.8k|
|Independent Director||1.8yrs||US$343.33k||0.0082% $507.4k|
Experienced Board: HQY's board of directors are considered experienced (5.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.
HealthEquity, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: HealthEquity, Inc.
- Ticker: HQY
- Exchange: NasdaqGS
- Founded: 2002
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$6.218b
- Shares outstanding: 70.88m
- Website: https://www.healthequity.com
Number of Employees
- HealthEquity, Inc.
- 15 West Scenic Pointe Drive
- Suite 100
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HQY||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jul 2014|
|2HE||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jul 2014|
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/23 02:48|
|End of Day Share Price||2020/02/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.